Concepts (235)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Research Design | 11 | 2023 | 402 | 2.790 |
Why?
|
| Suicide | 6 | 2023 | 126 | 1.760 |
Why?
|
| Analgesics, Opioid | 14 | 2022 | 241 | 1.570 |
Why?
|
| Suicide, Attempted | 10 | 2022 | 98 | 1.460 |
Why?
|
| Depression | 6 | 2022 | 518 | 1.310 |
Why?
|
| Chronic Pain | 12 | 2017 | 128 | 1.240 |
Why?
|
| Randomized Controlled Trials as Topic | 5 | 2020 | 342 | 1.220 |
Why?
|
| Humans | 67 | 2023 | 18430 | 1.060 |
Why?
|
| Smoking Cessation | 4 | 2014 | 199 | 0.990 |
Why?
|
| Precision Medicine | 2 | 2022 | 29 | 0.990 |
Why?
|
| Internet | 4 | 2014 | 243 | 0.980 |
Why?
|
| Hypertension, Pregnancy-Induced | 2 | 2022 | 41 | 0.960 |
Why?
|
| Suicidal Ideation | 6 | 2022 | 100 | 0.850 |
Why?
|
| Pragmatic Clinical Trials as Topic | 2 | 2020 | 56 | 0.850 |
Why?
|
| Models, Statistical | 5 | 2021 | 185 | 0.830 |
Why?
|
| Labetalol | 1 | 2022 | 9 | 0.830 |
Why?
|
| Confidentiality | 1 | 2022 | 30 | 0.820 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2022 | 34 | 0.810 |
Why?
|
| Middle Aged | 43 | 2022 | 8284 | 0.770 |
Why?
|
| Antidepressive Agents | 3 | 2021 | 162 | 0.770 |
Why?
|
| Schizophrenia | 3 | 2016 | 79 | 0.770 |
Why?
|
| Antipsychotic Agents | 3 | 2016 | 57 | 0.760 |
Why?
|
| Risk Assessment | 6 | 2021 | 1143 | 0.760 |
Why?
|
| Premature Birth | 1 | 2022 | 138 | 0.720 |
Why?
|
| Female | 46 | 2022 | 13136 | 0.720 |
Why?
|
| Opioid-Related Disorders | 9 | 2017 | 168 | 0.720 |
Why?
|
| Male | 43 | 2022 | 10440 | 0.710 |
Why?
|
| Mental Health | 5 | 2023 | 168 | 0.690 |
Why?
|
| Aged | 34 | 2022 | 6417 | 0.680 |
Why?
|
| Drug Prescriptions | 4 | 2020 | 157 | 0.670 |
Why?
|
| Adult | 34 | 2022 | 7910 | 0.650 |
Why?
|
| Outcome Assessment (Health Care) | 3 | 2017 | 254 | 0.640 |
Why?
|
| Electronic Health Records | 9 | 2021 | 747 | 0.610 |
Why?
|
| Self-Injurious Behavior | 3 | 2022 | 44 | 0.600 |
Why?
|
| Data Interpretation, Statistical | 2 | 2016 | 83 | 0.590 |
Why?
|
| Computer Simulation | 3 | 2017 | 85 | 0.560 |
Why?
|
| Longitudinal Studies | 8 | 2019 | 724 | 0.550 |
Why?
|
| Treatment Outcome | 11 | 2022 | 1296 | 0.550 |
Why?
|
| Propensity Score | 1 | 2017 | 94 | 0.550 |
Why?
|
| Patient Dropouts | 1 | 2016 | 23 | 0.540 |
Why?
|
| Process Assessment (Health Care) | 1 | 2016 | 28 | 0.540 |
Why?
|
| Bias | 3 | 2017 | 111 | 0.540 |
Why?
|
| Young Adult | 16 | 2020 | 2518 | 0.490 |
Why?
|
| Alcoholism | 4 | 2019 | 350 | 0.440 |
Why?
|
| Writing | 1 | 2012 | 12 | 0.420 |
Why?
|
| Review Literature as Topic | 1 | 2012 | 13 | 0.420 |
Why?
|
| Practice Patterns, Physicians' | 4 | 2022 | 350 | 0.410 |
Why?
|
| Risk Factors | 10 | 2023 | 3449 | 0.400 |
Why?
|
| Sample Size | 2 | 2023 | 30 | 0.400 |
Why?
|
| Odds Ratio | 3 | 2017 | 701 | 0.390 |
Why?
|
| Delivery of Health Care, Integrated | 3 | 2020 | 567 | 0.390 |
Why?
|
| Back Pain | 4 | 2022 | 33 | 0.390 |
Why?
|
| Adolescent | 12 | 2020 | 3798 | 0.370 |
Why?
|
| Depressive Disorder | 3 | 2017 | 231 | 0.360 |
Why?
|
| Primary Health Care | 6 | 2019 | 848 | 0.360 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 4 | 2015 | 39 | 0.360 |
Why?
|
| Osteoarthritis | 3 | 2014 | 23 | 0.350 |
Why?
|
| Surveys and Questionnaires | 10 | 2020 | 1389 | 0.320 |
Why?
|
| Epidemiologic Methods | 1 | 2008 | 87 | 0.320 |
Why?
|
| Exercise | 1 | 2013 | 495 | 0.310 |
Why?
|
| Aged, 80 and over | 12 | 2019 | 2003 | 0.300 |
Why?
|
| Risk Reduction Behavior | 4 | 2017 | 114 | 0.300 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2019 | 129 | 0.300 |
Why?
|
| Cohort Studies | 12 | 2021 | 2672 | 0.300 |
Why?
|
| Data Accuracy | 2 | 2019 | 27 | 0.290 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2021 | 131 | 0.290 |
Why?
|
| Cardiovascular Diseases | 1 | 2013 | 630 | 0.290 |
Why?
|
| Psychotherapy | 2 | 2017 | 59 | 0.280 |
Why?
|
| Mental Health Services | 2 | 2019 | 161 | 0.280 |
Why?
|
| Retrospective Studies | 7 | 2022 | 2550 | 0.270 |
Why?
|
| Community Mental Health Services | 2 | 2016 | 33 | 0.270 |
Why?
|
| Hypertension | 2 | 2021 | 524 | 0.260 |
Why?
|
| United States | 11 | 2022 | 4164 | 0.260 |
Why?
|
| Motivation | 3 | 2014 | 137 | 0.240 |
Why?
|
| Substance Abuse Detection | 2 | 2014 | 19 | 0.230 |
Why?
|
| Occupations | 2 | 2014 | 16 | 0.230 |
Why?
|
| Outpatients | 3 | 2019 | 111 | 0.230 |
Why?
|
| Logistic Models | 6 | 2019 | 962 | 0.220 |
Why?
|
| Occupational Exposure | 2 | 2014 | 67 | 0.220 |
Why?
|
| Antihypertensive Agents | 2 | 2022 | 172 | 0.220 |
Why?
|
| Machine Learning | 2 | 2022 | 44 | 0.220 |
Why?
|
| Counseling | 2 | 2015 | 197 | 0.210 |
Why?
|
| Methyldopa | 1 | 2022 | 6 | 0.210 |
Why?
|
| Nifedipine | 1 | 2022 | 7 | 0.210 |
Why?
|
| Patient Acuity | 1 | 2022 | 7 | 0.210 |
Why?
|
| International Classification of Diseases | 1 | 2022 | 87 | 0.210 |
Why?
|
| Patient Care | 1 | 2022 | 36 | 0.200 |
Why?
|
| Decision Making | 2 | 2014 | 204 | 0.200 |
Why?
|
| Informed Consent | 1 | 2021 | 20 | 0.200 |
Why?
|
| Severity of Illness Index | 4 | 2021 | 476 | 0.190 |
Why?
|
| Disability Evaluation | 2 | 2013 | 47 | 0.190 |
Why?
|
| Serotonin Uptake Inhibitors | 1 | 2021 | 74 | 0.190 |
Why?
|
| Pregnancy Outcome | 1 | 2022 | 159 | 0.190 |
Why?
|
| Health Services | 1 | 2022 | 117 | 0.190 |
Why?
|
| Pregnancy | 3 | 2022 | 1516 | 0.180 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2021 | 53 | 0.180 |
Why?
|
| Self Report | 6 | 2019 | 256 | 0.180 |
Why?
|
| Medicaid | 1 | 2022 | 211 | 0.180 |
Why?
|
| HIV Infections | 2 | 2017 | 695 | 0.180 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 90 | 0.180 |
Why?
|
| Eligibility Determination | 1 | 2020 | 17 | 0.180 |
Why?
|
| Depressive Disorder, Major | 1 | 2021 | 127 | 0.180 |
Why?
|
| Pain | 3 | 2017 | 84 | 0.180 |
Why?
|
| Washington | 5 | 2020 | 388 | 0.170 |
Why?
|
| Models, Psychological | 1 | 2019 | 25 | 0.170 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2020 | 27 | 0.170 |
Why?
|
| Alcohol Drinking | 2 | 2020 | 375 | 0.170 |
Why?
|
| Sleep | 3 | 2014 | 57 | 0.170 |
Why?
|
| Infant, Newborn | 1 | 2022 | 872 | 0.170 |
Why?
|
| Veterans | 2 | 2017 | 138 | 0.160 |
Why?
|
| Infant | 1 | 2022 | 1245 | 0.160 |
Why?
|
| Prescription Drug Misuse | 1 | 2017 | 11 | 0.150 |
Why?
|
| Models, Theoretical | 2 | 2014 | 76 | 0.150 |
Why?
|
| Biometry | 1 | 2017 | 13 | 0.140 |
Why?
|
| Regression Analysis | 2 | 2016 | 319 | 0.140 |
Why?
|
| Time Factors | 6 | 2016 | 1136 | 0.140 |
Why?
|
| Minority Groups | 1 | 2017 | 105 | 0.140 |
Why?
|
| Fibromyalgia | 1 | 2016 | 4 | 0.140 |
Why?
|
| Accidents, Traffic | 1 | 2016 | 15 | 0.140 |
Why?
|
| Vehicle Emissions | 2 | 2014 | 23 | 0.140 |
Why?
|
| Follow-Up Studies | 6 | 2016 | 1269 | 0.140 |
Why?
|
| Community-Institutional Relations | 1 | 2016 | 47 | 0.140 |
Why?
|
| Patient Care Planning | 1 | 2015 | 51 | 0.130 |
Why?
|
| Drug Administration Schedule | 4 | 2016 | 100 | 0.130 |
Why?
|
| Documentation | 1 | 2015 | 45 | 0.120 |
Why?
|
| European Continental Ancestry Group | 1 | 2017 | 554 | 0.120 |
Why?
|
| Cause of Death | 1 | 2016 | 185 | 0.120 |
Why?
|
| Environmental Monitoring | 1 | 2014 | 26 | 0.120 |
Why?
|
| Life Style | 2 | 2014 | 342 | 0.120 |
Why?
|
| Sex Factors | 2 | 2014 | 661 | 0.120 |
Why?
|
| Fatigue | 1 | 2014 | 35 | 0.120 |
Why?
|
| Urinalysis | 1 | 2013 | 9 | 0.120 |
Why?
|
| Tobacco Use Disorder | 1 | 2014 | 49 | 0.110 |
Why?
|
| Neuropsychological Tests | 1 | 2013 | 38 | 0.110 |
Why?
|
| Patients | 1 | 2014 | 38 | 0.110 |
Why?
|
| Electronic Mail | 1 | 2014 | 53 | 0.110 |
Why?
|
| Mass Screening | 1 | 2019 | 690 | 0.110 |
Why?
|
| Arthralgia | 1 | 2013 | 3 | 0.110 |
Why?
|
| Smoking | 2 | 2014 | 494 | 0.110 |
Why?
|
| Medication Adherence | 1 | 2016 | 267 | 0.110 |
Why?
|
| Patient Selection | 1 | 2014 | 198 | 0.100 |
Why?
|
| Mortality | 1 | 2013 | 123 | 0.100 |
Why?
|
| Social Support | 1 | 2013 | 214 | 0.100 |
Why?
|
| Risk | 3 | 2019 | 552 | 0.100 |
Why?
|
| United States Department of Veterans Affairs | 3 | 2017 | 126 | 0.100 |
Why?
|
| Cartilage, Articular | 1 | 2010 | 1 | 0.090 |
Why?
|
| Patella | 1 | 2010 | 1 | 0.090 |
Why?
|
| Knee Joint | 1 | 2010 | 4 | 0.090 |
Why?
|
| Osteoarthritis, Knee | 1 | 2010 | 11 | 0.090 |
Why?
|
| Predictive Value of Tests | 3 | 2019 | 365 | 0.090 |
Why?
|
| Pain Management | 3 | 2015 | 59 | 0.090 |
Why?
|
| Heart Diseases | 1 | 2010 | 77 | 0.080 |
Why?
|
| Women's Health | 1 | 2010 | 207 | 0.080 |
Why?
|
| Monte Carlo Method | 1 | 2008 | 17 | 0.080 |
Why?
|
| Low Back Pain | 1 | 2009 | 55 | 0.080 |
Why?
|
| Urinary Incontinence | 1 | 2009 | 33 | 0.080 |
Why?
|
| Drug Monitoring | 2 | 2021 | 22 | 0.080 |
Why?
|
| Prevalence | 3 | 2017 | 911 | 0.070 |
Why?
|
| Health Status | 1 | 2009 | 328 | 0.070 |
Why?
|
| Obesity | 2 | 2010 | 855 | 0.070 |
Why?
|
| Prospective Studies | 3 | 2017 | 1314 | 0.070 |
Why?
|
| Australia | 3 | 2009 | 23 | 0.060 |
Why?
|
| Double-Blind Method | 2 | 2015 | 165 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 2 | 2017 | 333 | 0.060 |
Why?
|
| Diabetes Mellitus | 1 | 2008 | 530 | 0.060 |
Why?
|
| Prognosis | 2 | 2017 | 624 | 0.060 |
Why?
|
| Educational Status | 2 | 2014 | 205 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2010 | 760 | 0.050 |
Why?
|
| Disease Susceptibility | 1 | 2022 | 46 | 0.050 |
Why?
|
| Policy | 1 | 2022 | 19 | 0.050 |
Why?
|
| Age Distribution | 2 | 2015 | 261 | 0.050 |
Why?
|
| Citalopram | 1 | 2021 | 14 | 0.050 |
Why?
|
| Ethics Committees, Research | 1 | 2021 | 11 | 0.050 |
Why?
|
| Fluoxetine | 1 | 2021 | 26 | 0.050 |
Why?
|
| United Kingdom | 1 | 2021 | 32 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2021 | 13 | 0.050 |
Why?
|
| Survival Analysis | 1 | 2021 | 226 | 0.050 |
Why?
|
| Forecasting | 1 | 2021 | 80 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2014 | 1173 | 0.050 |
Why?
|
| Community Health Centers | 1 | 2022 | 112 | 0.050 |
Why?
|
| Databases, Factual | 1 | 2021 | 327 | 0.040 |
Why?
|
| Algorithms | 1 | 2021 | 241 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2022 | 382 | 0.040 |
Why?
|
| Comorbidity | 1 | 2021 | 619 | 0.040 |
Why?
|
| Anticipation, Psychological | 1 | 2017 | 1 | 0.040 |
Why?
|
| Incidence | 1 | 2021 | 1314 | 0.040 |
Why?
|
| Likelihood Functions | 1 | 2017 | 48 | 0.040 |
Why?
|
| Interrupted Time Series Analysis | 1 | 2016 | 24 | 0.040 |
Why?
|
| Poisson Distribution | 1 | 2016 | 94 | 0.030 |
Why?
|
| Evidence-Based Practice | 1 | 2017 | 56 | 0.030 |
Why?
|
| Stakeholder Participation | 1 | 2016 | 23 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2016 | 160 | 0.030 |
Why?
|
| Control Groups | 1 | 2015 | 2 | 0.030 |
Why?
|
| Colorado | 1 | 2016 | 211 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2016 | 127 | 0.030 |
Why?
|
| Long-Term Care | 1 | 2015 | 22 | 0.030 |
Why?
|
| Hospitalization | 1 | 2021 | 847 | 0.030 |
Why?
|
| Linear Models | 1 | 2016 | 243 | 0.030 |
Why?
|
| Decision Support Techniques | 1 | 2016 | 95 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2015 | 198 | 0.030 |
Why?
|
| Air Pollutants, Occupational | 1 | 2014 | 16 | 0.030 |
Why?
|
| Interviews as Topic | 1 | 2015 | 327 | 0.030 |
Why?
|
| Drug Utilization | 1 | 2015 | 134 | 0.030 |
Why?
|
| Particulate Matter | 1 | 2014 | 29 | 0.030 |
Why?
|
| Health Surveys | 1 | 2015 | 269 | 0.030 |
Why?
|
| Attention | 1 | 2014 | 10 | 0.030 |
Why?
|
| Telephone | 1 | 2015 | 179 | 0.030 |
Why?
|
| Attitude | 1 | 2014 | 33 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2014 | 167 | 0.030 |
Why?
|
| ROC Curve | 1 | 2013 | 83 | 0.030 |
Why?
|
| Catastrophization | 1 | 2013 | 4 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 2014 | 253 | 0.030 |
Why?
|
| Fear | 1 | 2013 | 13 | 0.030 |
Why?
|
| User-Computer Interface | 1 | 2013 | 28 | 0.030 |
Why?
|
| Population Surveillance | 1 | 2014 | 271 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2013 | 96 | 0.030 |
Why?
|
| Sleep Wake Disorders | 1 | 2013 | 38 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2014 | 232 | 0.030 |
Why?
|
| Self Efficacy | 1 | 2012 | 71 | 0.030 |
Why?
|
| Stress, Psychological | 1 | 2013 | 147 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 399 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 1360 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2010 | 3 | 0.020 |
Why?
|
| Anthropometry | 1 | 2010 | 67 | 0.020 |
Why?
|
| Bone Density | 1 | 2010 | 96 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2012 | 673 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2010 | 105 | 0.020 |
Why?
|
| Disease Progression | 1 | 2010 | 271 | 0.020 |
Why?
|
| Hysterectomy | 1 | 2009 | 30 | 0.020 |
Why?
|
| Parity | 1 | 2009 | 74 | 0.020 |
Why?
|
| Life Expectancy | 1 | 2008 | 33 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2010 | 743 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2009 | 598 | 0.020 |
Why?
|
| Overweight | 1 | 2009 | 276 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2010 | 974 | 0.020 |
Why?
|
Concepts
(235)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(38)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_
-->